Objectives: We aimed to evaluate whether ultrasound (US) and microbubble-mediated delivery of Cluster of Differentiation 151 (CD151) could enhance the therapeutic effects of CD151 on myocardial infarction (MI). Methods: A rabbit model of MI was established by a modified Fujita method. Then, 50 MI rabbits were randomly divided into 5 groups, including G1 (CD151 plasmid and physiological saline in the presence of US); G2 (CD151 and Sonovue in the presence of US); G3 (CD151 and Sonovue in the absence of US); G4 (Sonovue in the absence of US), and a control group (physiological saline in the absence of US). After 14 days of treatment, the expression of CD151 was detected by Western blot. Besides, vessel density of peri-infarcted myocardium was measured by immunohistochemistry, and cardiac function was analyzed by echocardiography. Results: The rabbit model of MI was established successfully. CD151 injection increased the expression of CD151 and microvessel density in the myocardium of MI rabbits. Heart function was significantly improved by CD151, which exhibited increased left ventricular ejection fraction, left ventricular fractional shortening and a reduced Tei index. Besides, US Sonovue significantly increased the expression efficiency of CD151. Conclusion: US microbubble was an effective vector for CD151 delivery. CD151 might be an effective therapeutic target for MI.

Keywords:
Myocardial infarction, CD151, Ultrasound, Microbubbles
1.
Burke AP, Virmani R: Pathophysiology of acute myocardial infarction. Med Clin North Am 2007;91:553-572, ix.
2.
Matsuzawa Y, Lerman A: Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis 2014;25:713-724.
3.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB: Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014;129:e28-e292.
4.
French KM, Somasuntharam I, Davis ME: Self-assembling peptide-based delivery of therapeutics for myocardial infarction. Adv Drug Deliv Rev 2016;96:40-53.
5.
Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Liu J, Yu J, Zhou X, Hu J: Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2007;107:17-29.
6.
Mathieu E, Lamirault G, Toquet C, Lhommet P, Rederstorff E, Sourice S, Biteau K, Hulin P, Forest V, Weiss P, Guicheux J, Lemarchand P: Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. PLoS One 2012;7:e51991.
7.
Ertl G, Frantz S: Healing after myocardial infarction. Cardiovasc Res 2005;66:22-32.
8.
Wang QD, Pernow J, Sjoquist PO, Ryden L: Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 2002;55:25-37.
9.
Przybyt E, Harmsen MC: Mesenchymal stem cells: promising for myocardial regeneration? Curr Stem Cell Res Ther 2013;8:270-277.
10.
Ashman LK: CD151. J Biol Regul Homeost Agents 2002;16:223-226.
11.
Sadej R, Grudowska A, Turczyk L, Kordek R, Romanska HM: CD151 in cancer progression and metastasis: a complex scenario. Lab Invest 2014;94:41-51.
12.
Fu H, Tan J, Yin Q: Effects of recombinant adeno-associated virus-mediated CD151 gene transfer on the expression of rat vascular endothelial growth factor in ischemic myocardium. Exp Ther Med 2015;9:187-190.
13.
Xu H, Li Z, Si J: Nanocarriers in gene therapy: a review. J Biomed Nanotechnol 2014;10:3483-3507.
14.
Yoon YI, Kwon YS, Cho HS, Heo SH, Park KS, Park SG, Lee SH, Hwang SI, Kim YI, Jae HJ, Ahn GJ, Cho YS, Lee H, Lee HJ, Yoon TJ: Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system. Theranostics 2014;4:1133-1144.
15.
Zhang B, Hou YR, Chen T, Hu B: Microscopic study of ultrasound-mediated microbubble destruction effects on vascular smooth muscle cells. Asian Pac J Trop Med 2015;8:325-329.
16.
Roguin A, Avivi A, Nitecki S, Rubinstein I, Levy NS, Abassi ZA, Resnick MB, Lache O, Melamed-Frank M, Joel A, Hoffman A, Nevo E, Levy AP: Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci USA 2003;100:4644-4648.
17.
Reddy K, Khaliq A, Henning RJ: Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol 2015;7:243-276.
18.
Valensi P, Lorgis L, Cottin Y: Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis 2011;104:178-188.
19.
Scimia MC, Gumpert AM, Koch WJ: Cardiovascular gene therapy for myocardial infarction. Expert Opin Biol Ther 2014;14:183-195.
20.
Yla-Herttuala S, Martin JF: Cardiovascular gene therapy. Lancet 2000;355:213-222.
21.
Berditchevski F: Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 2001;114:4143-4151.
22.
Zheng ZZ, Liu ZX: Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration. Int J Biochem Cell Biol 2007;39:340-348.
23.
Zheng Z, Liu Z: CD151 gene delivery activates PI3k/Akt pathway and promotes neovascularization after myocardial infarction in rats. Mol Med 2006;12:214-220.
24.
Zaleska-Dorobisz U, Kaczorowski K, Pawlus A, Puchalska A, Inglot M: Ultrasound elastography - review of techniques and its clinical applications. Adv Clin Exp Med 2014;23:645-655.
25.
Wang YX, Leung KC, Cheung WH, Wang HH, Shi L, Wang DF, Qin L, Ahuja AT: Low-intensity pulsed ultrasound increases cellular uptake of superparamagnetic iron oxide nanomaterial: results from human osteosarcoma cell line U2OS. J Magn Reson Imaging 2010;31:1508-1513.
26.
Carmen JC, Nelson JL, Beckstead BL, Runyan CM, Robison RA, Schaalje GB, Pitt WG: Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J Infect Chemother 2004;10:193-199.
27.
Azagury A, Khoury L, Enden G, Kost J: Ultrasound mediated transdermal drug delivery. Adv Drug Deliv Rev 2014;72:127-143.
28.
Li Y, Wang J, Satterle A, Wu Q, Liu F: Gene transfer to skeletal muscle by site-specific delivery of electroporation and ultrasound. Biochem Biophys Res Commun 2012;424:203-207.
29.
Azmin M, Harfield C, Ahmad Z, Edirisinghe M, Stride E: How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. Curr Pharm Des 2012;18:2118-2134.
30.
Unger E, Porter T, Lindner J, Grayburn P: Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev 2014;72:110-126.
31.
Zhou XY, Liao Q, Pu YM, Tang YQ, Gong X, Li J, Xu Y, Wang ZG: Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin Med J (Engl) 2009;122:2711-2717.
32.
Nande R, Greco A, Gossman MS, Lopez JP, Claudio L, Salvatore M, Brunetti A, Denvir J, Howard CM, Claudio PP: Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer. Curr Gene Ther 2013;13:163-174.
33.
Chen ZY, Lin Y, Yang F, Jiang L, Ge S: Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles. Cardiovasc Ultrasound 2013;11:11.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.